IgA nephropathy is a progressive autoimmune kidney disease that can lead to kidney failure in up to 50% of patients over time
doi:10.1136/bjsports-2019-101961
However, recent data also suggest that astrocytes may be involved in systemic energy balance control
[1][2] Experts warn that non-approved compounds might contain impurities, incorrect concentrations, or additives that pose risks
Recent discussions around Tylenol and autism highlight just how important it is to view medication use in a broader context
Relevant Updates to the Interim Bulk Drug Substances List for 503A Pharmacies 2,4,5,6 For a full list of updates, please download the complete Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act document linked above